245 related articles for article (PubMed ID: 10379636)
21. Comparison of different glomerular filtration methods in the elderly: which formula provides better estimates?
Aras S; Varli M; Uzun B; Atli T; Keven K; Turgay M
Ren Fail; 2012; 34(4):435-41. PubMed ID: 22268784
[TBL] [Abstract][Full Text] [Related]
22. Pregnancy reduces the accuracy of the estimated glomerular filtration rate based on Cockroft-Gault and MDRD formulas.
Koetje PM; Spaan JJ; Kooman JP; Spaanderman ME; Peeters LL
Reprod Sci; 2011 May; 18(5):456-62. PubMed ID: 21079240
[TBL] [Abstract][Full Text] [Related]
23. Validity of creatinine clearance estimates in the assessment of renal function.
Luke DR; Halstenson CE; Opsahl JA; Matzke GR
Clin Pharmacol Ther; 1990 Nov; 48(5):503-8. PubMed ID: 2225710
[TBL] [Abstract][Full Text] [Related]
24. Antihypertensive therapy in the aged patient. Clinical pharmacokinetic considerations.
Piepho RW; Fendler KJ
Drugs Aging; 1991 May; 1(3):194-211. PubMed ID: 1686570
[TBL] [Abstract][Full Text] [Related]
25. Iohexol plasma clearance measurement in older adults with chronic kidney disease-sampling time matters.
Ebert N; Loesment A; Martus P; Jakob O; Gaedeke J; Kuhlmann M; Bartel J; Schuchardt M; Tölle M; Huang T; van der Giet M; Schaeffner E
Nephrol Dial Transplant; 2015 Aug; 30(8):1307-14. PubMed ID: 26044836
[TBL] [Abstract][Full Text] [Related]
26. Cystatin C as a marker of renal function in kidney transplant patients.
Mendiluce A; Bustamante J; Martin D; Santos M; Bustamante R; Pascual P; Jabary NS; Castañeda A; Muñoz MA
Transplant Proc; 2005 Nov; 37(9):3844-7. PubMed ID: 16386559
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and dosage adjustment in patients with renal dysfunction.
Verbeeck RK; Musuamba FT
Eur J Clin Pharmacol; 2009 Aug; 65(8):757-73. PubMed ID: 19543887
[TBL] [Abstract][Full Text] [Related]
28. [Comparison of six radionuclidic and non-radionuclidic methods for the assessment of glomerular filtration rate in patients with chronic renal failure].
Fotopoulos A; Bokharhli JA; Tsiouris S; Katsaraki A; Papadopoulos A; Tsironi M; Theodorou J
Hell J Nucl Med; 2006; 9(2):133-40. PubMed ID: 16894423
[TBL] [Abstract][Full Text] [Related]
29. Utility of endogenous creatinine clearance as a measure of renal function in mice.
Dunn SR; Qi Z; Bottinger EP; Breyer MD; Sharma K
Kidney Int; 2004 May; 65(5):1959-67. PubMed ID: 15086941
[TBL] [Abstract][Full Text] [Related]
30. Renal hemodynamics and pharmacokinetics of bevantolol in patients with impaired renal function.
Solimon M; Massry SG; Campese VM
Am J Cardiol; 1986 Nov; 58(12):21E-24E. PubMed ID: 2878596
[TBL] [Abstract][Full Text] [Related]
31. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients.
Caspi D; Lubart E; Graff E; Habot B; Yaron M; Segal R
Arthritis Rheum; 2000 Jan; 43(1):103-8. PubMed ID: 10643705
[TBL] [Abstract][Full Text] [Related]
32. Effects of orange juice on the pharmacokinetics of atenolol.
Lilja JJ; Raaska K; Neuvonen PJ
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):337-40. PubMed ID: 15983823
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke.
Strid S; Borgå O; Edenius C; Jostell KG; Odergren T; Weil A
Eur J Clin Pharmacol; 2002 Sep; 58(6):409-15. PubMed ID: 12242600
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of measured and calculated creatinine clearances as glomerular filtration markers in different stages of liver cirrhosis.
Orlando R; Floreani M; Padrini R; Palatini P
Clin Nephrol; 1999 Jun; 51(6):341-7. PubMed ID: 10404694
[TBL] [Abstract][Full Text] [Related]
35. Comparison of estimated glomerular filtration rate with estimated creatinine clearance in the dosing of drugs requiring adjustments in elderly patients with declining renal function.
Spruill WJ; Wade WE; Cobb HH
Am J Geriatr Pharmacother; 2008 Aug; 6(3):153-60. PubMed ID: 18775390
[TBL] [Abstract][Full Text] [Related]
36. A comparison of measured creatinine clearance versus calculated glomerular filtration rate for assessment of renal function before autologous and allogeneic BMT.
Hahn T; Yao S; Dunford LM; Thomas J; Lohr J; Arora P; Battiwalla M; Smiley SL; McCarthy PL
Biol Blood Marrow Transplant; 2009 May; 15(5):574-9. PubMed ID: 19361749
[TBL] [Abstract][Full Text] [Related]
37. Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation.
Vervoort G; Willems HL; Wetzels JF
Nephrol Dial Transplant; 2002 Nov; 17(11):1909-13. PubMed ID: 12401845
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of population with normal serum creatinine impaired renal function and: the validation of a MDRD formula in a healthy general population.
Kang YS; Han KH; Han SY; Kim HK; Cha DR
Clin Nephrol; 2005 Apr; 63(4):258-66. PubMed ID: 15847252
[TBL] [Abstract][Full Text] [Related]
39. Novel algorithm for more accurate calculation of renal function in adults with cancer.
Holweger K; Lipp HP; Dietz K; Hartmann JT; Bokemeyer C
Ann Pharmacother; 2008 Dec; 42(12):1749-57. PubMed ID: 19033483
[TBL] [Abstract][Full Text] [Related]
40. Effect of fenofibrate on kidney function: a 6-week randomized crossover trial in healthy people.
Ansquer JC; Dalton RN; Caussé E; Crimet D; Le Malicot K; Foucher C
Am J Kidney Dis; 2008 Jun; 51(6):904-13. PubMed ID: 18501783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
